Mirum Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference
29 Mayo 2020 - 9:05AM
Business Wire
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical
company focused on the development and commercialization of novel
therapies for debilitating liver diseases, today announced that
Chris Peetz, president and chief executive officer at Mirum will
present at the virtual Jefferies 2020 Healthcare Conference on June
2, 2020 at 10:00 a.m. Pacific Time/1:00 p.m. Eastern Time.
A live audio webcast and archive of the presentation will be
available in the Investors & Media section of the company
website at ir.mirumpharma.com.
About Mirum Pharmaceuticals
Mirum Pharmaceuticals, Inc. is a clinical-stage
biopharmaceutical company focused on the development and
commercialization of a late-stage pipeline of novel therapies for
debilitating liver diseases. The company’s lead product candidate,
maralixibat, is an investigational oral drug in development for
Alagille syndrome (ALGS) and progressive familial intrahepatic
cholestasis (PFIC). For more information, visit mirumpharma.com.
Follow Mirum on Twitter, Facebook and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200529005401/en/
Investor contact: Ian Clements, Ph.D. ir@mirumpharma.com
Media contact: Erin Murphy media@mirumpharma.com
Mirum Pharmaceuticals (NASDAQ:MIRM)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Mirum Pharmaceuticals (NASDAQ:MIRM)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
